Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06245954
Other study ID # ZRJY2021-BJ08-03-02
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date December 31, 2026

Study information

Verified date January 2024
Source China-Japan Friendship Hospital
Contact Mingming Deng, MD
Phone 86 18801336854
Email isdeng1017@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to conduct a prospective randomized controlled trial to design simulator and in vitro lung standardized training, to perform a learning curve evaluation of transbronchial lung cryobiopsy (TBLC) operating physicians, and to assess the role of standardized training in TBLC.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date December 31, 2026
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years - suspected ILD. - =3 months since HRCT - Forced vital capacity (FVC) =50% of predicted value - Diffused lung carbon monoxide (DLCO) =35% predicted value - Echocardiography = 12 months - Estimated pulmonary artery systolic pressure =40 mmHg - Body mass index (BMI) =35 kg/m2 - Patient consent for experimentation Exclusion Criteria: - Patients with platelet counts less than 50 × 109/L or prothrombin time international normalized ratio (INR) higher than 1.5 - Patients refused to participate in the experiment

Study Design


Intervention

Other:
simulated training
Simulation training of bronchoscopists by means of simulators and extracorporeal lungs
traditional bedside teaching
TBLC training for bronchoscopists through traditional lectures, hands-on demonstrations

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
China-Japan Friendship Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Obtain pathologic quality assessment of specimens The quality of TBLC sampling specimens was scored by two professional pathologists on a specialized pathology scale. 1 month
Primary histopathological pattern diagnosis rate Diagnosis of histopathological patterns was performed by two specialized pathologists to determine a consistent diagnostic rate. 1 month
Primary diagnostic rate of multidisciplinary discussions Diagnostic rates based on composite TBLC, BAL, clinical and imaging data in a multidisciplinary discussion by clinical experts 1 month
Secondary Occurrence of short-term adverse events bleeding and pneumothorax occurred with 24 hours after TBLC, acute exacerbation of ILD and death occurred with 7 days after TBLC 24 hours or 7 days
See also
  Status Clinical Trial Phase
Completed NCT04285463 - Defining Optimal Settings for Transbronchial Lung Cryobiopsy II: An Ex-Vivo Human Lungs Model Study for Improvement of Specimen Quality N/A
Not yet recruiting NCT03958162 - The Comparison of Uniportal and Tubeless Video Assisted Thoracic Surgery and Transbronchial Lung Cryobiopsy in the Diagnosis of Interstitial Lung Disease N/A